Citation
89 FR 20486
Multiple canonical documents share this first-page citation.
- Center for Scientific Review; Notice of Closed Meetings Friday, March 22, 2024 89 FR 20486
- Prospective Grant of an Exclusive Patent License: Adoptive T Cell Therapy Products Produced Using a Pharmacological p38 Mitogen-Activated Protein Kinase (MAPK) Inhibitor Friday, March 22, 2024 89 FR 20486